Síndrome de Guillain-Barré como manifestación neurológica autoinmune asociado a COVID-19: Una revisión de la literatura

The coronavirus disease (COVID-19) caused by SARS-CoV-2 has been a challenge for health services around the world. The pandemic has spread widely, with more than 80 million confirmed cases and more than one million deaths globally. There have been many studies to understand all aspects of the diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Naranjo Arango, Yonatan Andrés, García Henao, Juan Pablo, Farfán Cortés, Abraham Yamit Amin Ariff, Álvarez Correa, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. 2022
Materias:
Artículo De Revisión
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914014/
http://dx.doi.org/10.1016/j.rcreu.2021.01.004
Descripción
Sumario:The coronavirus disease (COVID-19) caused by SARS-CoV-2 has been a challenge for health services around the world. The pandemic has spread widely, with more than 80 million confirmed cases and more than one million deaths globally. There have been many studies to understand all aspects of the disease. Recently, several cases have been reported of patients with Guillain-Barré syndrome associated with COVID-19 as the main manifestation. As it may be one of the first autoimmune neurological diseases triggered by SARS-CoV-2, it is necessary to obtain more information to fully understand the immunopathogenic mechanisms involved in this association.

Ejemplares similares